Chief Business Officer – Roy Wallen

Cre8MDI is excited to welcome Roy Wallen of Directional Healthcare Advisors to our team. Roy has come alongside to act as Chief BusinPicture1ess Officer and brings his expertise in medical device management and marketing to take Cre8MDI to the next level. Roy began working with us since May and has already tightened our pitch deck, presented in front of investors, and helped us to streamline our demonstration kit. A note from Roy:

The Cre8MDI team has demonstrated great progress toward establishing a new standard of care in predicting cardiovascular disease. With the existing, patent-pending capabilities and our combined start-up experience, I look forward to working with David and the team to execute on the product program that is supported and endorsed by the Massachusetts Life Sciences Center and individual investors.  The Cardio 1:1 System promises to be an easy-to-use and reliable tool to help clinicians manage the leading cause of death in the world.


Cre8MDI Receives MLSC MAP Grant

Cre8MDI is pleased to announce that it has been honored to receive a Milestone Achievement Grant (MAP) from the Massachusetts Life Science Center (MLSC) in the amount of $200,000. The MLSC Board approved the first round of Milestone Achievement Program on Tuesday, May 26th.

 “The MLSC’s Milestone Achievement Program provides an excellent opportunity for early-stage companies to grow and develop within Massachusetts’ fast-growing innovation economy,” said Governor Charlie Baker.

This new grant program was created to address the need of early-stage life science companies to reach critical value. The MLSC awarded more than $2million in funds to Massachusetts companies in order to support their work toward completion or fulfillment of a defined milestone.

It was a very competitive grant program with many life science companies vying for the funds. The MSLC determined that Cre8MDI met all the criteria and had a clear milestone driven proposal. The Board of Directors, Peer Reviewers, SAB, and Center staff were involved with reviewing the company’s business plan, science and future potential.

“We are pleased to be supporting Cre8MDI with this grant funding to help the company achieve a milestone in their product development” said MLSC Vice President for Communications & Marketing Angus McQuilken.  “Cre8MDI is part of a vibrant and growing life sciences community in the Merrimack Valley that is creating jobs, while bringing technologies to market that will improve patient care and human health.”

David Cassidy, President of Cre8MDI stated, “This grant will fund our next stage of development. We are pleased with the validation this grant provides our company as we move forward to predict cardiovascular disease with ease.”

Official MLSC Press Release:

MAP Grant Press Release by Cre8MDI FINAL


“Working with a combination of the right investors and advisors

is a secret ingredient to start up success.”   -David Roth, FORBES

Cre8MDI has aligned itself with a team of advisors who are experts in their field.

Dr. Viachaslau Barodka, and team at Johns Hopkins University School of Medicine, Medical and Scientific Advisor

Dr. Barodka is the chief contact at Johns Hopkins University School of Medicine for clinical input and testing.  He is joined by a world renowned team that has been studying and writing papers on PWV for many years including Dr. Dan Berkowitz, Dr. Daniel Nyhan and Dr. Jochen Steppan. They all see many uses for the technology we’ve created and how to apply it within the PWV arena.

Dr. Amad Tayebi, Legal Adviser (Patent Law)

Dr. Tayebi is a patent attorney involved in preparation and prosecution of patent applications, infringement, and validity opinions.  He has authored numerous technical and law articles and 25 U.S. patents.  Dr. Tayebi, professor at the University of Massachusetts, also has extensive research, industrial and business experience in the fields of thermoforming, fibrous structures and processing of fibrous materials, filtration, fluid transfer through porous media, fiber-reinforced composites, respiratory protective devices and design of automated assembly equipment.


Cre8MDI’s team has over 25 years of experience and has brought a number of medical devices from concept to market.

Mr. David Cassidy – President and Founder
Mr. Roy Wallen – Chief Business Officer
Mrs. Marie Getchell – VP Quality and Regulatory
Mr. Mark Lewis – VP Operations & Manufacturing
Mr. Brett Allen – Senior Software Engineer
Mrs. Allison Reveley – Marketing & Public Relations
Cre8 logo 2.0 (1)

The multi-disciplined team has expertise in the ares of:

  • Biomedical Engineering                             
  • Mechanical Engineering
  • Electronics Engineering                                            
  • Software Development
  • Instrument & Disposable Manufacturing             
  • Quality Control
  • Regulatory, FDA, MDD, ISO, CFDA, PMDA               
  • Industrial Design & Human Factors
  • Manufacturing
  • Management

Our President & Founder – David Cassidy

David Cassidy profileDavid Cassidy is president and founder of Cre8MDI, LLC, a medical device, start-up company. Cre8MDI’s mission is to develop and commercialize innovative diagnostic devices that will improve the quality of healthcare and reduce cost through early detection of disease. This echoes David’s lifelong commitment to helping others. David has more than 25 years’ experience in the medical device industry including heart assist and IV infusion. He has taken a number of medical devices from concept through production and has authored multiple patents.  

David’s most recent success comes as co-founder and inventor for Enginivity LLC,  where he created and brought to production a sophisticated, mobile IV fluid warmer called enFlow™. Enginivity LLC was sold 3-1/2 years after the product’s inception to Vital Signs, a GE Healthcare company.  

David resides in Massachusetts with his wife and four sons. He enjoys exploring the Southwest with his family, hiking and restoring and building cars.